|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma显示文摘 | Roniel Cabrera Miguel Ararat Yiling Xu Todd Brusko Clive Wasserfall Mark A. Atkinson Lung Ji Chang Chen Liu David R. Nelson | 2013 | Cancer Immunology Immunotherapy2013，，4： | 3 |
| 2 | Extraction of berberine from rhizome of Coptis chinensis Franch using supercritical uid extraction显示文摘 | Liu Ben Li Wenjing Chang Yiling | 2006 | Journal ofPharmaceutical and Biomedical Analysis2006，41，： | 1 |
| 3 | Treatment of methyl methacrylate from semiconductor wastewater by catalytic wet oxidation显示文摘 | Ji Darren Chang Chiachi Wu Yiling | 2010 | Journal of Taiwan Institute of Chemical Engineers2010，41，2： | 1 |
| 4 | Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma显示文摘 | Roniel Cabrera Miguel Ararat Yiling Xu Todd Brusko Clive Wasserfall Mark A. Atkinson Lung Ji Chang Chen Liu David R. Nelson | 2013 | Cancer Immunology, Immunotherapy2013，，： | 1 |
| 5 | Extraction of berberine from rhizome of Coptis chinensis Franch using supercritical fluid extraction显示文摘 | Liu Ben Li Wenjing Chang Yiling | 2006 | Journal of Pharmaceutical and Biomedical Analysis2006，41，： | 1 |
| 6 | Extraction of berberine from rhizome of Coptis chinensis Franch using supercritical fluid extraction显示文摘 | IAu Ben Li Wenjing Chang Yiling | 2006 | Journal of Pharmaceutical and Biomedical Analysis2006，41，3： | 1 |
| 7 | Extraction of berberine from rhizome of Coptis chinensis Franch using supercritical fluid extraction显示文摘 | LIU Ben LI Wenjing CHANG Yiling | 2006 | Journal of Pharmaceutical and Biomedical Analysis(0731-7085)2006，41，： | 1 |
| 8 | Extraction of berberine from rhizome of Coptis chinensis Franch using supercritical fluid extraction显示文摘 | Ben Liu Wenjing Li Yiling Chang | 2006 | Pharmaceutical and Biomedical Analysis2006，41，3： | 1 |
| 9 | Clinical evaluation of 4D dynamic dose for thoracic tumor stereotactic body radiation therapy with variable parameters显示文摘Objective:To evaluate the dose uncertainty in stereotactic body radiation therapy induced by respiratory motion using a 4D dynamic dose(4DDD)reconstruction method.Methods:A retrospective analysis was conducted on five lung cancer patients who received static intensitymodulated radiation therapy.The 4DDD was constructed using beam delivery log files,four-dimensional computed tomography(4DCT)scans,and treatment plans.To evaluate the impact of respiratory motion,4DDD calculations were performed with 10 starting phases for each field.A total of 270 field doses were simulated and calculated.The differences between the cumulative volume histogram in whole-course treatment and the field doses'gamma passing rate(GPR)were compared.The correlations between plan complexity metrics and the dose deviation caused by respiratory motion were evaluated independently.The phase distributions of 398 subfields were calculated and evaluated for the influence of dose rate and breathing frequency.Results:The GPRs of all fields were different among various starting phases,with the highest range from 62.20% to 76.87% for 2 mm/3%GPR.The deviation of mean point dose was(5.42±5.21)%,and the deviation in the mean dose and D98% within the internal gross tumor volume were(0.97±0.71)% and(0.77±0.53)%,respectively.There was a significant correlation between the beam aperture-to-volume(BA2V)ratio and the average 2 mm/2%GPR(R?0.601,P<0.01).Lower dose rates led to a more homogeneous distribution of phases among subfields(t?44.100,P<0.001).Conclusions:Different beam starting phases had a limited impact on the overall treatment evaluation.However,the respiratory motion could be observed to induce dose deviations using the 4DDD reconstruction model,particularly for fields with small BA2V. | Yiling Zeng Yu Chang Sheng Zhang Jun Han Hongyuan Liu Feng Xiao Bo Pang Bin Hu Junping Cheng Hong Quan Zhiyong Yang | 2023 | Radiation Medicine and Protection2023，4，3： | 0 |
| 10 | Progress in the preparation,identification and biological activity of walnut peptides显示文摘Walnuts are rich in protein and are a high-quality plant protein resource.In recent years,with the growth of consumer demand for functional food and food for special medical purpose,the use of walnut protein for the preparation of functional walnut peptide ingredients or additives and other compositions has received increasing attention.However,the improvement of the yield of walnut peptides and the clarification of their functional activities are the bottlenecks that limit the development of these peptides.To this end,this article reviews the pretreatment,preparation,purification and identification processes of walnut peptides,as well as their biological activities such as antioxidant activity,antitumour activity,improvement of memory,antihypertension and regulation of metabolic disorders are elaborated to provide a reference for the industrial development of walnut peptides. | Chang Liu Zijie Zhang Yuting Shang Siting Li Junxi Xia Yiling Tian Yingmin Jia Aijin Ma | 2024 | Journal of Future Foods2024，4，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员